Clinical Trial: WR 279,396 for the Treatment of Cutaneous Leishmaniasis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open-Label Study to Examine the Safety and Efficacy, of WR 279,396 (Paromomycin + Gentamicin Topical Cream) for the Treatment of Cutaneous Leishmaniasis in France

Brief Summary: The objectives of the study are to evaluate the safety and efficacy of open label treatment with WR 279,396 (topical paromomycin & gentamicin) in patients with non-complicated, non-severe cutaneous leishmaniasis (CL).